Morgan Stanley’s Liminal BioSciences Inc. Common Shares LMNL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,706
| Closed | -$10.7K | – | 7748 |
|
|
2023
Q2 | $10.7K | Buy |
+1,706
| New | +$10.7K | ﹤0.01% | 6792 |
|
|
2023
Q1 | – | Sell |
-6
| Closed | -$20 | – | 7877 |
|
|
2022
Q4 | $20 | Hold |
6
| – | – | ﹤0.01% | 7769 |
|
|
2022
Q3 | $0 | Sell |
6
-1,386
| -100% | – | ﹤0.01% | 8000 |
|
|
2022
Q2 | $7K | Hold |
1,392
| – | – | ﹤0.01% | 7340 |
|
|
2022
Q1 | $14K | Sell |
1,392
-4,443
| -76% | -$44.7K | ﹤0.01% | 7294 |
|
|
2021
Q4 | $63K | Buy |
5,835
+3,671
| +170% | +$39.6K | ﹤0.01% | 6703 |
|
|
2021
Q3 | $50K | Hold |
2,164
| – | – | ﹤0.01% | 6731 |
|
|
2021
Q2 | $84K | Buy |
2,164
+1,282
| +145% | +$49.8K | ﹤0.01% | 6433 |
|
|
2021
Q1 | $37K | Buy |
882
+727
| +469% | +$30.5K | ﹤0.01% | 6497 |
|
|
2020
Q4 | $7K | Sell |
155
-18
| -10% | -$813 | ﹤0.01% | 6727 |
|
|
2020
Q3 | $19K | Sell |
173
-3,474
| -95% | -$382K | ﹤0.01% | 6094 |
|
|
2020
Q2 | $394K | Buy |
3,647
+152
| +4% | +$16.4K | ﹤0.01% | 4718 |
|
|
2020
Q1 | $233K | Buy |
3,495
+1,818
| +108% | +$121K | ﹤0.01% | 4799 |
|
|
2019
Q4 | $140K | Buy |
+1,677
| New | +$140K | ﹤0.01% | 5547 |
|